Press Releases

GSK and adesso develop digital solution for reliable adherence to treatment

British biopharmaceutical company GSK is relying on the expertise of IT service provider adesso to enhance digital patient care. Together, the two partners have developed DREAM (Digital Reminders for Adherence of Medicines and Vaccines), a digital reminder service for medication intake and vaccination appointments. After launching in five pilot markets, the project has become a global success story. Today, DREAM is live in 23 markets around the world, including the UK, Spain, Italy and numerous emerging markets.

At the heart of the project lies a fundamental challenge in healthcare: how to support patients in consistently following their treatment plans and attending vaccination appointments. In collaboration with adesso, GSK has developed DREAM to address exactly this need. The digital solution sends patients personalised information and reminders – reliable, easy to understand and seamlessly integrated into everyday life. A simple but effective solution that improves lives sustainably.


A strong and equal partnership – international and long-term

To develop and scale the solution globally across multiple regulatory environments, GSK needed an experienced technology partner. With its agile approach and deep expertise, internationally active IT service provider adesso proved to be the right choice. Working closely together, the partners created a flexible system that can quickly adapt to changing requirements and is deployable worldwide.

Necati Sebe, Head of Commercial Operations and Strategy at GSK, explains: ‘One of core values at GSK is to make a positive impact on people’s lives. With DREAM, we have created a pioneering solution to improve adherence to medications and vaccinations. We chose adesso because their team works with flexibility, focus and exceptional commitment – even when faced with complex challenges. This partnership has enabled us to create a simple solution for a complex problem.’

Necati Sebe is Head of Commercial Operations and Strategy at GSK. (Source: GSK)

adesso UK has been supporting GSK for around 18 months with the implementation and development of DREAM. This close and trusting collaboration has played a key role in the project’s success. Today, DREAM is being rolled out to additional countries and laying the foundation for future digital patient services at GSK.

Libero Raspa, Managing Director at adesso UK, adds: ‘GSK is a strong brand with a clear vision: to improve everyday life for patients through digital solutions. With our agile approach, we were able to guide the project dynamically and resolve challenges quickly in close coordination. DREAM is a great example of how technology can deliver tangible impact – for better healthcare around the world.’

Libero Raspa is Managing Director of adesso UK. (Source: adesso)

Press service

Materials for media reports

With our press service, we provide you with various materials that complement our corporate news or serve as background information.

To the press service

Do you have any questions?

Do you have any questions about our press service or a specific request? Please contact us.

Contact